Ozempic and the Food Industry — Who's Losing?

Join host Nick Ledger as he follows the money behind Ozempic's transformation of America's food industry. When millions stop craving snacks, entire sectors feel the squeeze—from shrinking grocery aisles to panicking restaurant chains. Discover which companies are losing and how much in this eye-opening investigation.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Nick Ledger examines how GLP-1 medications are reshaping American grocery stores by 2030. We discuss Circana's projection that GLP-1 households will drive 35% of food sales, analyzing spending shifts away from snacks toward protein and fresh produce, store redesigns prioritizing health products, and the multi-billion-dollar impact on legacy food brands struggling to adapt.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Nick Ledger explores how GLP-1 drugs like Ozempic are reshaping America's restaurant industry, as six million users eating 700 fewer calories daily drive an 8% spending drop at fast-food chains. From vanishing add-on purchases to struggling coffee shops, the episode examines the economic tremors hitting an industry built on abundance—and the survival strategies emerging.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Host Nick Ledger examines how GLP-1 drugs like Ozempic are reshaping America's food economy. With households reducing grocery spending by 5.3% and savory snacks dropping 10.1%, the snack industry faces unprecedented decline. Cornell research shows 23% of U.S. households already have GLP-1 users, projected to reach 35% by 2030.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.